[HTML][HTML] Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - ncbi.nlm.nih.gov
A major factor hindering the exploration of adoptive immunotherapy in preclinical settings is
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - dash.harvard.edu
A major factor hindering the exploration of adoptive immunotherapy in preclinical settings is
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - mdanderson.elsevierpure.com
A major factor hindering the exploration of adoptive immunotherapy in preclinical settings is
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
[引用][C] Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - cir.nii.ac.jp
Human melanoma immunotherapy using tumor antigen-specific T cells generated in
humanized mice | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
humanized mice | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
[PDF][PDF] Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - pdfs.semanticscholar.org
ABSTRACT A major factor hindering the exploration of adoptive immunotherapy in
preclinical settings is the limited availability of tumor-reactive human T cells. Here we …
preclinical settings is the limited availability of tumor-reactive human T cells. Here we …
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - pubmed.ncbi.nlm.nih.gov
A major factor hindering the exploration of adoptive immunotherapy in preclinical settings is
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
[HTML][HTML] Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - oncotarget.com
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized
mice | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …
mice | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice.
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - europepmc.org
A major factor hindering the exploration of adoptive immunotherapy in preclinical settings is
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
the limited availability of tumor-reactive human T cells. Here we developed a humanized …
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice
Z Hu, J Xia, W Fan, J Wargo, YG Yang - Oncotarget, 2016 - oncotarget.com
Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized
mice | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …
mice | Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board …